SHALLAK, MARIAM

SHALLAK, MARIAM  

DIPARTIMENTO DI MEDICINA E INNOVAZIONE TECNOLOGICA  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line 1-gen-2022 Pilotti, E.; Cannata, A.; Magnani, G.; Bignami, F.; Corsi, A.; Valenti, M. T.; Shallak, M.; Forlani, G.; Romanelli, M. G.
Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T cell leukemia 1-gen-2021 Forlani, Greta; Shallak, Mariam; Tedeschi, Alessandra; Cavallari, Ilaria; Marçais, Ambroise; Hermine, Olivier; Accolla, Roberto S
HTLV-1 Infection and Adult T Cell Leukemia Mechanisms of Oncogenesis and Alteration of Immunity 1-gen-2021 Accolla, Roberto S.; Forlani, Greta; Shallak, Mariam
Htlv-1 infection and pathogenesis: New insights from cellular and animal models 1-gen-2021 Forlani, G.; Shallak, M.; Accolla, R. S.; Romanelli, M. G.
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma 1-gen-2022 Gatta, A; Celesti, F; Chiaravalli, Am; Cerati, M; Shallak, M; Tedeschi, A; Sessa, F; Accolla, Rs; Forlani, G
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 1-gen-2023 Azzi, L.; Dalla Gasperina, D.; Veronesi, G.; Shallak, M.; Maurino, V.; Baj, A.; Gianfagna, F.; Cavallo, P.; Dentali, F.; Tettamanti, L.; Maggi, F.; Maffioli, L. S.; Tagliabue, A.; Accolla, R. S.; Forlani, G.
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 1-gen-2022 Azzi, L.; Dalla Gasperina, D.; Veronesi, G.; Shallak, M.; Ietto, G.; Iovino, D.; Baj, A.; Gianfagna, F.; Maurino, V.; Focosi, D.; Maggi, F.; Ferrario, M. M.; Dentali, F.; Carcano, G.; Tagliabue, A.; Maffioli, L. S.; Accolla, R. S.; Forlani, G.
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA 1-gen-2023 Celesti, F.; Gatta, A.; Shallak, M.; Chiaravalli, A. M.; Cerati, M.; Sessa, F.; Accolla, R. S.; Forlani, G.
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1 1-gen-2019 Forlani, G.; Shallak, M.; Ramia, E.; Tedeschi, A.; Accolla, R. S.
The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing 1-gen-2022 Shallak, M.; Alberio, T.; Fasano, M.; Monti, M.; Iacobucci, I.; Ladet, J.; Mortreux, F.; Accolla, R. S.; Forlani, G.
The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy 1-gen-2023 Forlani, G.; Shallak, M.; Gatta, A.; Shaik, A. K. B.; Accolla, R. S.
Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells 1-gen-2022 Celesti, F; Azzi, L; Shallak, M; Gatta, A; Accolla, Rs; Forlani, G
Unveiling the hidden treasury: Ciita-driven mhc class ii expression in tumor cells to dig up the relevant repertoire of tumor antigens for optimal stimulation of tumor specific cd4+ t helper cells 1-gen-2020 Forlani, G.; Shallak, M.; Celesti, F.; Accolla, R. S.